Rigel Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Summary

Rigel Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company. The company is engaged in the discovery and development of novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. The company develops its products based on signaling pathways and related targets that are critical to disease mechanisms. The company principally operates in the U.S. with its headquarters in South San Francisco.

Global Markets Direct's Rigel Pharmaceuticals, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Rigel Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • History
  • SWOT Analysis
  • SWOT Analysis - Overview
  • Rigel Pharmaceuticals, Inc. - Strengths
  • Rigel Pharmaceuticals, Inc. - Strengths - Strategic Alliances
  • Rigel Pharmaceuticals, Inc. - Strengths - Strategic Approach to Product Discovery
  • Rigel Pharmaceuticals, Inc. - Strengths - Strong Patent Portfolio
  • Rigel Pharmaceuticals, Inc. - Weaknesses
  • Rigel Pharmaceuticals, Inc. - Weaknesses - Lack of Manufacturing Facilities
  • Rigel Pharmaceuticals, Inc. - Weaknesses - Pending Lawsuits
  • Rigel Pharmaceuticals, Inc. - Opportunities
  • Rigel Pharmaceuticals, Inc. - Opportunities - Focused Area of Research
  • Rigel Pharmaceuticals, Inc. - Opportunities - Pipeline Products
  • Rigel Pharmaceuticals, Inc. - Opportunities - Growth in Incidence of Diseases
  • Rigel Pharmaceuticals, Inc. - Opportunities - Changing Demographics
  • Rigel Pharmaceuticals, Inc. - Threats
  • Rigel Pharmaceuticals, Inc. - Threats - Competition
  • Rigel Pharmaceuticals, Inc. - Threats - Impact of Regulations
  • Rigel Pharmaceuticals, Inc. - Threats - High Risk of Developing Promising Products
  • Rigel Pharmaceuticals, Inc. - Threats - Impact of the Financial Crisis
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Locations And Subsidiaries - Head Office
  • Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Rigel Pharmaceuticals, Inc., Key Facts
  • Major Products and Services
  • Rigel Pharmaceuticals, Inc., History
  • Rigel Pharmaceuticals, Inc., Key Employees
  • Rigel Pharmaceuticals, Inc., Key Employee Biographies
  • Rigel Pharmaceuticals, Inc., Ratios based on current share price
  • Rigel Pharmaceuticals, Inc., Annual Ratios
  • Rigel Pharmaceuticals, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Rigel Pharmaceuticals, Inc., Ratio Charts